You are here

  • Home
  • Archive
  • Volume 22, Issue 5
  • Value of screening for and treating pre-diabetes is reduced by low test accuracy and indirect evidence of impact on patient important outcomes

Article Text

Article menu
Download PDFPDF
Commentary
Primary care
Value of screening for and treating pre-diabetes is reduced by low test accuracy and indirect evidence of impact on patient important outcomes
  1. Neri A Alvarez-Villalobos1,2,
  2. Rene Rodriguez-Gutierrez1,3,
  3. Victor M Montori1,4
  1. 1 Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota, USA
  2. 2 Department of Research Unit, University Hospital ‘Dr Jose E Gonzalez’ Autonomous University of Nuevo Leon, Rochester, Minnesota, USA
  3. 3 Division of Endocrinology, University Hospital ‘Dr Jose E Gonzalez’ Autonomous University of Nuevo Leon, Monterrey, Nuevo Leon, Mexico
  4. 4 Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota, USA
  1. Correspondence to Dr Victor M Montori, Knowledge and Evaluation Research Unit and Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, 200 First Street SW, Rochester, MN 55902, USA; Montori.Victor{at}mayo.edu

https://doi.org/10.1136/ebmed-2017-110754

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Barry E, Roberts S, Oke J, et al. Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions. BMJ 2017;356:i6538.

    Context

    Type 2 diabetes is a major cause of morbidity and mortality. Hoping to reduce the burden of diabetes on people and societies, guidelines have recommended screening for hyperglycaemia in healthy population.1 These recommendations assume that early detection and intervention can prevent the morbimortality associated with type 2 diabetes and its complications.1 The systematic review by Barry et al sought to evaluate the accuracy of screening and the efficacy of early intervention (lifestyle or metformin) to prevent type 2 diabetes1.

    Methods

    They conducted a rigorous systematic review of the published literature until June 2016. They then conducted two meta-analyses. The first one, a bivariate random-effects model meta-analysis, summarised …

    View Full Text

    Footnotes

    • Competing interests None declared.

    • Provenance and peer review Commissioned; internally peer reviewed.